Bank of New York Mellon’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.1K | Sell |
20,284
-197
| -1% | -$281 | ﹤0.01% | 4261 |
|
|
2026
Q1 | $34.6K | Hold |
20,481
| – | – | ﹤0.01% | 4157 |
|
|
2025
Q4 | $40.6K | Buy |
20,481
+9,818
| +92% | +$31.4K | ﹤0.01% | 4147 |
|
|
2025
Q3 | $31K | Hold |
10,663
| – | – | ﹤0.01% | 4148 |
|
|
2025
Q2 | $19.3K | Sell |
10,663
-99,995
| -90% | -$178K | ﹤0.01% | 4114 |
|
|
2025
Q1 | $166K | Sell |
110,658
-136
| -0.1% | -$343 | ﹤0.01% | 3926 |
|
|
2024
Q4 | $261K | Buy |
110,794
+2,952
| +3% | +$51.8K | ﹤0.01% | 3853 |
|
|
2024
Q3 | $3.17M | Sell |
107,842
-33,005
| -23% | -$760K | ﹤0.01% | 2540 |
|
|
2024
Q2 | $1.74M | Buy |
140,847
+21,558
| +18% | +$454K | ﹤0.01% | 2875 |
|
|
2024
Q1 | $2.42M | Sell |
119,289
-13,129
| -10% | -$303K | ﹤0.01% | 2667 |
|
|
2023
Q4 | $2.98M | Sell |
132,418
-2,686
| -2% | -$56.7K | ﹤0.01% | 2630 |
|
|
2023
Q3 | $2.25M | Buy |
135,104
+3,739
| +3% | +$74.1K | ﹤0.01% | 2753 |
|
|
2023
Q2 | $3.22M | Buy |
131,365
+4,080
| +3% | +$98.3K | ﹤0.01% | 2578 |
|
|
2023
Q1 | $3.07M | Sell |
127,285
-2,365
| -2% | -$65.5K | ﹤0.01% | 2560 |
|
|
2022
Q4 | $3.83M | Buy |
129,650
+856
| +0.7% | +$30.8K | ﹤0.01% | 2492 |
|
|
2022
Q3 | $5.39M | Buy |
128,794
+12,408
| +11% | +$335K | ﹤0.01% | 2256 |
|
|
2022
Q2 | $3.27M | Sell |
116,386
-6,607
| -5% | -$167K | ﹤0.01% | 2548 |
|
|
2022
Q1 | $4.57M | Buy |
122,993
+712
| +0.6% | +$30.2K | ﹤0.01% | 2475 |
|
|
2021
Q4 | $5.34M | Sell |
122,281
-1,270
| -1% | -$66.6K | ﹤0.01% | 2437 |
|
|
2021
Q3 | $7.67M | Sell |
123,551
-7,808
| -6% | -$652K | ﹤0.01% | 2263 |
|
|
2021
Q2 | $11.2M | Sell |
131,359
-15,226
| -10% | -$816K | ﹤0.01% | 2072 |
|
|
2021
Q1 | $6.59M | Sell |
146,585
-21,016
| -13% | -$827K | ﹤0.01% | 2316 |
|
|
2020
Q4 | $1.14M | Buy |
167,601
+32,313
| +24% | +$288K | ﹤0.01% | 3184 |
|
|
2020
Q3 | $1.56M | Hold |
135,288
| – | – | ﹤0.01% | 2818 |
|
|
2020
Q2 | $417K | Buy |
135,288
+57,583
| +74% | +$261K | ﹤0.01% | 3565 |
|
|
2020
Q1 | $320K | Buy |
77,705
+55,600
| +252% | +$368K | ﹤0.01% | 3574 |
|
|
2019
Q4 | $115K | Hold |
22,105
| – | – | ﹤0.01% | 4006 |
|
|
2019
Q3 | $26K | Hold |
22,105
| – | – | ﹤0.01% | 4164 |
|
|
2019
Q2 | $27K | Hold |
22,105
| – | – | ﹤0.01% | 4174 |
|
|
2019
Q1 | $29K | Sell |
22,105
-171
| -0.8% | -$196 | ﹤0.01% | 4134 |
|
|
2018
Q4 | $19K | Hold |
22,276
| – | – | ﹤0.01% | 4163 |
|
|
2018
Q3 | $22K | Sell |
22,276
-17,349
| -44% | -$26.4K | ﹤0.01% | 4205 |
|
|
2018
Q2 | $81K | Sell |
39,625
-1,248
| -3% | -$10.7K | ﹤0.01% | 4030 |
|
|
2018
Q1 | $289K | Buy |
40,873
+207
| +0.5% | +$1.4K | ﹤0.01% | 3812 |
|
|
2017
Q4 | $163K | Sell |
40,666
-1,145
| -3% | -$4.62K | ﹤0.01% | 3991 |
|
|
2017
Q3 | $171K | Sell |
41,811
-98
| -0.2% | -$350 | ﹤0.01% | 3904 |
|
|
2017
Q2 | $174K | Buy |
41,909
+17,224
| +70% | +$81.3K | ﹤0.01% | 3929 |
|
|
2017
Q1 | $154K | Buy |
24,685
+2,410
| +11% | +$10.9K | ﹤0.01% | 3939 |
|
|
2016
Q4 | $88K | Sell |
22,275
-364
| -2% | -$1.69K | ﹤0.01% | 4046 |
|
|
2016
Q3 | $158K | Sell |
22,639
-1,042
| -4% | -$17.3K | ﹤0.01% | 3943 |
|
|
2016
Q2 | $363K | Hold |
23,681
| – | – | ﹤0.01% | 3664 |
|
|
2016
Q1 | $370K | Hold |
23,681
| – | – | ﹤0.01% | 3556 |
|
|
2015
Q4 | $290K | Sell |
23,681
-56
| -0.2% | -$741 | ﹤0.01% | 3744 |
|
|
2015
Q3 | $305K | Buy |
23,737
+56
| +0.2% | +$707 | ﹤0.01% | 3758 |
|
|
2015
Q2 | $286K | Sell |
23,681
-14,973
| -39% | -$205K | ﹤0.01% | 3797 |
|
|
2015
Q1 | $511K | Buy |
38,654
+50
| +0.1% | +$675 | ﹤0.01% | 3598 |
|
|
2014
Q4 | $549K | Sell |
38,604
-391
| -1% | -$6.77K | ﹤0.01% | 3580 |
|
|
2014
Q3 | $1.07M | Sell |
38,995
-25
| -0.1% | -$760 | ﹤0.01% | 3247 |
|
|
2014
Q2 | $1.57M | Buy |
39,020
+30,215
| +343% | +$1.12M | ﹤0.01% | 3046 |
|
|
2014
Q1 | $339K | Buy |
8,805
+1,015
| +13% | +$35.8K | ﹤0.01% | 3700 |
|
|
2013
Q4 | $265K | Sell |
7,790
-9
| -0.1% | -$239 | ﹤0.01% | 3779 |
|
|
2013
Q3 | $149K | Sell |
7,799
-1,420
| -15% | -$24.8K | ﹤0.01% | 3863 |
|
|
2013
Q2 | $143K | Buy |
+9,219
| New | +$195K | ﹤0.01% | 3845 |
|
Other funds holding FLNA
GCP
MOS
NA
AWM
Bank of New York Mellon's FLNA Position: Q2 2026 in Review
Bank of New York Mellon reduced its Filana Therapeutics (FLNA) stake by 0.96% in Q2 2026, selling an estimated $281 and leaving 20,284 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4261.
Bank of New York Mellon first reported a position in FLNA in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.2M in Q2 2021. 45 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.
- Bank of New York Mellon held 20,284 shares of Filana Therapeutics worth $24.1K as of Q2 2026.
- Bank of New York Mellon sold 197 Filana Therapeutics shares in Q2 2026, an estimated $281.
- Filana Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4261 holding.
- Bank of New York Mellon first reported a position in Filana Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Filana Therapeutics position peaked at $11.2M in Q2 2021.
- 45 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.